Retroperitoneal High Grade Undifferentiated Pleomorphic Sarcoma as a Second Metachronous Neoplasm Following Intracranial Meningioma

Armin Kamyab, Michael John Jacobs

.

DOI: 10.4236/jct.2011.24070                

Abstract

Introduction: Meningiomas and retroperitoneal sarcomas are two distinct rare tumors, with an incidence of 2 and 0.4 cases per 100,000 respectively. Case Report: We report the case of a 39 year old woman with a history of intracranial meningioma who was found two months later to have a large retroperitoneal sarcoma on CT scan after presenting to the emergency department complaining of abdominal pain. Pathologic evaluation was consistent with a high grade undifferentiated sarcoma. Discussion: It is highly unusual for a 39 year old otherwise healthy patient to present with two rare, seemingly unrelated tumors. It is our suspicion that there is a genetic component involved, however to date no association has been described in the literature between intracranial meningiomas and extracranial sarcomas. Conclusion: Besides being the first report of a retroperitoneal sarcoma occurring as a second metachronous neoplasm following an intracranial meningioma, we suspect that there is a genetic component involved. Further studies may indicate a genetic mutational link.

Keywords

Meningioma, Sarcoma, Genetic

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	M. P. Buetow, P. C. Buetow and J. G. Smirniotopoulos, “Typical, Atypical, and Misleading Features in Meningioma,” Radiographics, Vol. 11, No. 6, 1991, pp. 1087-1106.
[2]	M. Rohringer, G. R. Sutherland, D. F. Louw and A. A. Sima, “Incidence and Clinicopathological Features of Meningioma,” Journal of Neurosurgery, Vol. 71, No. 5, 1989, pp. 665-672. doi:10.3171/jns.1989.71.5.0665
[3]	K. Striedinger, S. R. Vandenberg, G. S. Baia, et al., “The Neurofibromatosis 2 Tumor Suppressor Gene Product, Merlin, Regulates Human Mingioma Cell Growth by Signaling through YAP,” Neoplasia, Vol. 10, No. 11, 2008, pp. 1204-1212.
[4]	F. J. Staal, R. B. Van Der Luijt, M. R. Baert, et al., “A Novel Germline Mutation of PTEN Associated with Brain Tumors of Multiple Lineages,” British Journal of Cancer, Vol. 86, No. 10, 2002, pp. 1586-1591. doi:10.1038/sj.bjc.6600206
[5]	B. J. Goldsmith, W. M. Wara, C. B. Wilson, et al., “Postoperative Irradiation for Subtottaly Resected Mingiomas. A Restrospective Analysis of 140 Patients Treated from 1967 to 1990,” Journal of Neurosurgery, Vol. 80, No. 2, 1994, pp. 195-201. doi:10.3171/jns.1994.80.2.0195
[6]	G. Wrobel, P. Roerig, F. Kokocinski, et al., “Microarrawy-Based Gene Expression Profiling of Benign, Atypical and Anaplastic Meningiomas Identified Novel Genes Associated with Meningioma Progression,” International Journal of Cancer, Vol. 114, No. 2, 2005, pp. 249-256. doi:10.1002/ijc.20733
[7]	W. C. Olivero, et al., “The Natural History and Growth Rate of Asymptomatic Meningiomas: A Review of 60 Patients,” Journal of Neurosurgery, Vol. 83, No. 2, 1995, pp. 222-224. doi:10.3171/jns.1995.83.2.0222
[8]	C. Maros, M. Hassler, K. Roessler, et al., “Meningioma,” Critical Reviews in Oncology/Hematology, Vol. 67, No. 2, 2008, pp. 153-171. doi:10.1016/j.critrevonc.2008.01.010
[9]	I. Francis, R. Cohan and D. Varma, “Sondak V. Retroperitoneal Sarcomas,” Cancer Imaging, Vol. 5, No. 1, 2005, pp. 89-94. doi:10.1102/1470-7330.2005.0019
[10]	J. Mullinax, J. Zager and R. Gonzalez, “Current Diagnosis and Management of Retroperitoneal Sarcoma,” Cancer Control, Vol. 18, No. 3, 2011, pp. 177-187.
[11]	S. Bonvalot, M. Rivoir, M. Castaing, et al., “Primary Retroperitoneal Sarcomas: A Multivariate Analysis of Surgical Factors Associated with Local Control,” Journal of Clinical Oncology, Vol. 27, No. 1, 2009, pp. 31-37. doi:10.1200/JCO.2008.18.0802
[12]	R. Daylami, A. Amiri, B. Goldsmith, et al., “Inferior Vena Cava Leiomyosarcomas: Is Reconstruction Necessary after Resection?” Journal of the American College of Surgeons, Vol. 210, No. 2, 2010, pp. 185-190. doi:10.1016/j.jamcollsurg.2009.10.010